Physica Medica: European Journal of Medical Physics - Volume 32 - Supplement 1 - February 2016
|
9th National Congress of the Associazione Italiana di Fisica Medica |
2 |
|
Editors Board |
3 |
|
Contents |
5 |
|
New Scenarios in Radiotherapy |
6 |
|
A.01 DOSIMETRIC COMPARISON OF 3D-CONFORMAL RADIOTHERAPY, INTENSITY-MODULATED RADIOTHERAPY AND VOLUMETRICMODULATED ARC THERAPY FOR UPPER ABDOMINAL TUMORS |
6 |
|
A.02 DOSIMETRY IN TOTAL BODY IRRADIATION: A MEASUREMENT SET TO CHARACTERIZE THE TREATMENT TECHNIQUE |
6 |
|
A.03 REPRODUCIBILITY AND SENSITIVITY OF IQM: A REAL-TIME MONITORING DEVICE FOR COMPLEX RADIOTHERAPY TREATMENTS |
6 |
|
A.04 IN VIVO DOSIMETRY WITH DIODE AND SETUP VERIFICATION THROUGH GAF CHROMIC RTQA IN IORT FOR BREAST IRRADIATION |
7 |
|
A.05 A DOSE-VOLUME PARAMETER ANALYSIS OF THE BLADDER IN THREEDIMENSIONAL CONFORMAL RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER |
7 |
|
A.06 LOCAL NTCP TO PREDICT LUNG TISSUE DENSITY CHANGES ON FOLLOWUP CT AFTER LUNG CANCER IMRT |
7 |
|
A.07 FLATTENING FILTER FREE (FFF) RAPID ARC FOR SINGLE FRACTION SBRT OF THE LUNG REDUCES TREATMENT TIME AND IS DOSIMETRICALLY EQUIVALENT TO FLATTENING FILTER VMAT |
7 |
|
A.08 A COMPARISON BETWEEN DIFFERENT PATIENT QA DEVICES FOR IMRT TREATMENTS ON VERO SYSTEM |
8 |
|
A.09 FDG-PET POSITIVE LYMPH NODE VARIATIONS DURING IMAGE-GUIDED IMRT FOR HEAD AND NECK CANCER IDENTIFY NON-RESPONDING PATIENTS |
8 |
|
A.10 DEVELOPMENT OF AN ADAPTIVE RADIOTHERAPY METHOD USING PORTAL IMAGING AND CBCT |
8 |
|
A.11 SBRT OF PROSTATE AND SEMINAL VESICLES WITH TOMOTHERAPY: FEASIBILITY AND DOSIMETRIC RESULTS |
9 |
|
A.12 RADIOTHERAPY INTER-FRACTION BLADDER SETUP VARIATIONS FOR CERVICAL CANCER PATIENTS ASSESSED WITH A CBCT |
9 |
|
A.13 DOSIMETRICAL EVALUATIONS BY CALCULATING EQD2, EUD AND NTCP IN IMAGE GUIDED VAGINAL HDR BRACHYTHERAPY |
9 |
|
A.14 BONE TEXTURE ANALYSIS AS PREDICTIVE FACTOR OF RADIATIONINDUCED DAMAGE IN PELVIC RADIOTHERAPY TREATMENT |
9 |
|
A.15 HIFU GENERATED FAST HYPERTHERMIA AS A NEW OPTION FOR GLIOBLASTOMA TREATMENT |
10 |
|
A.16 COMPARISON OF STATIC AND ROTATIONAL IMRT TECHNIQUES IN THREE DOSE LEVEL PLANS FOR HEAD AND NECK CANCER |
10 |
|
A.17 TOWARDS ADAPTIVE TOMOTHERAPY: ASSESSMENT OF PLANNING CT TO MVCT DEFORMABLE IMAGE REGISTRATION RELIABILITY FOR “DOSE OF THE DAY” CALCULATION IN HEAD AND NECK |
10 |
|
A.18 CHARACTERIZATION AND COMPARISON OF TWO EPID-BASED SOFTWARE SOLUTIONS FOR IN-VIVO DOSIMETRY OF VMAT TREATMENTS |
11 |
|
A.19 STEREOTACTIC RADIOTHERAPY IN THE RETREATMENT OF RECURRENT CERVICAL CANCERS |
11 |
|
A.20 THREE-ISOCENTER JAGGED-JUNCTION IMRT OF CRANIOSPINAL IRRADIATION: TREATMENT PLANNING AND PRE-TREATMENT VERIFICATIONS |
11 |
|
A.21 IMRT PRE-TREATMENT VERIFICATION, 2D VS 4D: PROBLEMS ASSOCIATED WITH THE COUCH ATTENUATION |
11 |
|
A.22 VALIDATION OF A DEFORMABLE IMAGE REGISTRATION ALGORITHM FOR RADIOTHERAPY APPLICATIONS |
12 |
|
A.23 ELEKTA ONCENTRA 4.3 AND MONACO 5.0 COMPARISON FOR 3DCRT DOSE CALCULATION ALGORITHMS |
12 |
|
A.24 RE-IRRADIATION (RE-RT) OF HEAD AND NECK CANCER (HNC): DOSE ACCUMULATION USING DEFORMABLE IMAGE REGISTRATION (DIR) AND COMPARISON WITH RIGID REGISTRATION (RIR) |
12 |
|
A.25 RAPIDPLAN MODELS BASED ON HELICAL TOMOTHERAPY (HT) PROSTATE PLANS FOR VMAT OPTIMIZATION |
13 |
|
A.26 SMALL FIELD CHARACTERIZATION OF TRUEBEAM FFF BEAMS WITH A NEW STEREOTACTIC DIODE: A MULTICENTER STUDY |
13 |
|
A.27 QUALITY ASSURANCE OF RAPIDARC RADIOTHERAPY DELIVERY SYSTEM: RA-COMMISSIONING TEST RESULTS |
13 |
|
A.28 ACCURACY OF A DEFORMABLE IMAGE REGISTRATION ALGORITHM |
14 |
|
A.29 INNOVATIVE APPROACHES IN THE DOSIMETRY OF LASER-DRIVEN PROTON BEAMS FOR FUTURE HADRONTHERAPY APPLICATIONS |
14 |
|
A.30 PATIENT-SPECIFIC PLAN QA IN ACTIVE PENCIL BEAM SCANNING WITH PROTON AND CARBON ION BEAMS: A NEW SOFTWARE SOLUTION TO SUPPORT TREATMENT PLANNING WORKFLOW |
14 |
|
A.31 DEVELOPMENT AND APPLICATION OF A TRANS-RECTAL US PROBE INTEGRATED WITH MOSKIN DOSIMETERS: IN VIVO RECTAL WALL MEASUREMENTS DURING HDR PROSTATE BRACHYTHERAPY |
14 |
|
A.32 COMPARISON OF FOUR DIODES FOR BASIC DOSIMETRY: OUTPUT FACTORS, PERCENTAGE DEPTH DOSE CURVES AND PROFILES FOR FIELD SIZES FROM 0.8 TO 10.4 CM |
15 |
|
A.33 LINAC COUCH TOP ATTENUATION IN ROTATIONAL RADIOTHERAPY TREATMENTS: CLINICAL CONSEQUENCES |
15 |
|
A.34 CHARACTERIZATION OF THE ENERGY DEPENDENT RESPONSE OF EBT3 RADIOCHROMIC FILM TO PROTON AND CARBON ION BEAMS |
15 |
|
A.35 SBRT PRE-TREATMENT QA |
16 |
|
A.36 THE ROLE OF PINNACLE3 SCRIPTING IN STREAMLINING IMRT AND 3D-CRT TREATMENT PLANNING |
16 |
|
A.37 CLEAR AND FILL IN MONACO 5.0: IS IT FEASIBLE TO DELIVER HIGH DOSE WITH LOW MONITOR UNITS IN STEREOTACTIC BODY RADIATION THERAPY (SBRT) FOR LUNG CANCER? |
16 |
|
A.38 IMPLEMENTATION OF A QUALITY ASSURANCE METHOD FOR VMAT TECHNIQUES ON AN ELEKTA SYNERGY LINAC USING AN IN-HOUSE DEVELOPED SOFTWARE AND A ROTATIONAL PHANTOM |
17 |
|
A.39 DOSE ACCUMULATION AND REPLANNING IN H&N PATIENT: A STEP TOWARD IMPLEMENTATION OF ART IN CLINICAL PRACTICE |
17 |
|
A.40 MODELLING SEVERE LATE RECTAL BLEEDING: RESULTS ON A LARGE POOLED POPULATION OF PROSTATE CANCER PATIENTS |
17 |
|
A.41 AN INNOVATIVE TOOL FOR IMAGE GUIDED INTRA-OPERATIVE RADIOTHERAPY (IGIORT): THE VALIDATION PROCESS OF A DEDICATED TREATMENT PLANNING SYSTEM |
17 |
|
A.42 REFERENCE DOSIMETRY FOR IOERT DEDICATED MOBILE LINACS: HOW DO WE APPLY INTERNATIONAL DOSIMETRIC PROTOCOLS? |
18 |
|
A.43 USING STATISTICAL PROCESS CONTROL (SPC) FOR PATIENT-SPECIFIC VMAT QUALITY ASSURANCE: A SIX-YEAR RETROSPECTIVE ANALYSIS ON 1200 PATIENTS |
18 |
|
A.44 OPTIMAL DOSE PRESCRIPTION IN LINAC-BASED STEREOTACTIC EXTRACRANIAL RADIOTHERAPY (SBRT) WITH VMAT TECHNIQUE: AN INVESTIGATION USING “PARETO FRONTS” |
18 |
|
A.45 EPID-BASED IN-VIVO DOSIMETRY FOR VMAT TREATMENT DOSE VERIFICATION: INITIAL CLINICAL EXPERIENCE |
19 |
|
A.46 COMMISSIONING OF THE 4-D TREATMENT DELIVERY SYSTEM FOR ORGAN MOTION MANAGEMENT IN SCANNING PARTICLE BEAMS |
19 |
|
A.47 USE OF RADIOCHROMIC FILMS IN HDR IR-192 BRACHYTHERAPY DOSIMETRY |
19 |
|
A.48 POTENTIAL RADIATION-INDUCED MESOTHELIOMA AMONGST LONGTERM SOLID CANCER SURVIVORS |
20 |
|
A.49 CELL IRRADIATION TO INVESTIGATE MARKERS OF IONIZING RADIATIONINDUCED DNA DAMAGE |
20 |
|
A.50 TOTAL BODY IRRADIATION: A TRADITIONAL TECHNIQUE RECONSIDERED IN THE LIGHT OF TREATMENT PLANNING SYSTEM |
20 |
|
A.51 COMBINED RT AND EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR MONOCLONAL ANTIBODY-MOAB-EGFR TREATMENT OF HEAD AND NECK CANCER (HNC): RADIOBIOLOGICAL MODEL FOR FAMOSO |
20 |
|
A.52 INTEGRATION OF FMRI AND MEG FUNCTIONAL MAPS INTO A CYBERKNIFE PLANNING SYSTEM: FEASIBILITY STUDY FOR MOTOR ACTIVITY LOCALIZATION AND DOSE PLANNING |
21 |
|
A.53 SUM SIGNAL FILM DOSIMETRY: A NOVEL APPROACH FOR HIGH DOSE PATIENT SPECIFIC QUALITY ASSURANCE WITH GAFCHROMIC EBT3 |
21 |
|
A.54 EXRADIN A26 MICROCHAMBER CHARACTERIZATION FOR SMALL FIELD DOSIMETRY |
21 |
|
A.55 FIELD-IN-FIELD VERSUS 3D-DYNAMIC WEDGE TECHNIQUES FOR PATIENTS WITH BREAST CANCER: A PRELIMINARY STUDY |
22 |
|
A.56 AAA VERSUS PBC ALGORITHM FOR LUNG CANCER TREATMENT PLANNING: DOSIMETRIC ANALYSIS FOR TARGET VOLUME AND ORGAN AT RISK |
22 |
|
A.57 GEL DOSIMETERS FOR RADIOTHERAPY APPLICATIONS: RESULTS OF A “RESEARCH PROJECT OF NATIONAL INTEREST” (PRIN) |
22 |
|
A.58 EXPLOITING THE MACHINE LOG FILES FOR VMAT AND IMRT TREATMENT VERIFICATION |
23 |
|
A.59 WEB-INTERFACEDMONTE CARLO SIMULATION FOR QUALITY ASSURANCE IN RADIATION THERAPY |
23 |
|
A.60 A SIMPLIFIED INTENSITY-MODULATED RADIOTHERAPY TECHNIQUE FOR THE BREAST TO REDUCE POSTERIOR PART OF THE AXILLA IRRADIATION |
23 |
|
A.61 RADIOTHERAPY IN ASSOCIATIONWITHHYPERTHERMIA: OUTCOME AND TOXICITY IN THE TREATMENT OF SUPERFICIAL RECURRENT/METASTATIC TUMORS |
23 |
|
A.62 SR-EBRT: SYNCHROTRON RADIATION EXTERNAL BEAM ROTATIONAL RADIOTHERAPY FOR BREAST CANCER TREATMENT |
24 |
|
A.63 A MULTIMODALITY RADIOTHERAPY TESTED NETWORK PLATFORM FOR REVIEW OF ULTRASOUND IMAGES |
24 |
|
A.64 RADIOTHERAPY IN BREAST CANCER WITH VOLUNTARY DEEPINSPIRATION BREATH-HOLD USING BRAINLAB EXACTRAC |
24 |
|
A.65 EVALUATION OF DELIVERY ACCURACY OF HEAD AND NECK RADIOTHERAPY WITH CONSTANT DOSE RATE VMAT |
25 |
|
A.66 VOLUMETRIC MODULATED ARC THERAPY FOR DELIVERY OF HEAD AND NECK RADIOTHERAPY: COMPARISON BETWEEN CONSTANT AND VARIABLE DOSE RATE |
25 |
|
A.67 A COMPARATIVE PLAN ANALYSIS: CONSTANT DOSE RATE VMAT AND STEP-AND-SHOOT IMRT IN HEAD AND NECK CANCER |
25 |
|
A.68 EVALUATION OF SUPERFICIAL DOSE IN TOMOTHERAPY: A PHANTOM STUDY |
25 |
|
A.69 THE NEUTRON CONTAMINATION IN RADIOTHERAPY TREATMENTS WITH PHOTON AND ELECTRON BEAMS: DY ACTIVATION MEASUREMENTS |
26 |
|
A.70 LOCAL IMPLEMENTATION OF TSEI: PHYSICAL ASPECTS |
26 |
|
A.71 CHARACTERIZATION OF OSLD DETECTORS FOR DOSIMETRIC CHECKS ON CLINICAL PHOTON BEAM |
26 |
|
A.72 CHARACTERIZATION OF A COMMERCIAL EPID 3D SOFTWARE FOR VMAT VERIFICATIONS |
26 |
|
A.73 CHARACTERIZATION OF HIGH-DOSE-PER-PULSE INTRAOPERATIVE RADIATION THERAPY ELECTRON BEAMS BY USING A MICRODIAMOND DOSIMETER |
27 |
|
A.74 COMPARISON BETWEEN 2D AND 3D IMRT PRE-TREATMENT VERIFICATION |
27 |
|
A.75 PATIENT SPECIFIC CBCT CALIBRATION FOR DOSIMETRIC EVALUATION OF HYBRID RT-PLAN |
27 |
|
A.76 IMPROVING THE QUALITY OF PROTONTHERAPY TREATMENT PLANS AND THEIR VERIFICATION WITH MONTE CARLO METHODS |
28 |
|
A.77 A NEW PHANTOM FOR DAILY QA IN PROTONTHERAPY: A FAST, RELIABLE AND INEXPENSIVE SOLUTION |
28 |
|
A.78 PATIENT QUALITY ASSURANCE FOR HD TOMOTHERAPY®: A 3-YEAR REVIEW OF PRE-TREATMENT IN-PHANTOM DOSIMETRY |
28 |
|
A.79 YOURELASTICSOLUTION GROUP: MULTI-INSTITUTIONAL STUDY TO EVALUATE DIR ALGORITHMS FOR STRUCTURE DELINEATION VIA COMPUTATIONAL PHANTOMS |
29 |
|
A.80 IMPACT OF IMAGE QUALITY ON DEFORMABLE IMAGE REGISTRATION PERFORMANCES IN PELVIS PATIENTS |
29 |
|
A.81 ROBUST VMAT OPTIMIZATION IN LUNG SBRT WITH A COMMERCIAL SYSTEM |
29 |
|
A.82 QUANTITATIVE EVALUATION OF AUTOMATIC PLANNING SYSTEM: COMPARISON WITH DIFFERENT MANUAL PLANNING FOR LIVER SBRT TREATMENTS |
29 |
|
A.83 PHENOL COMPOUNDS AS NEW MATERIALS FOR ELECTRON SPIN RESONANCE DOSIMETRY IN RADIOTHERAPY |
30 |
|
A.84 LONG PERIOD ACCURACY AND REPRODUCIBILITY OF MLC LEAVES POSITION ACQUIRED IN A DAILY QA PROGRAM USING EPID IMAGES |
30 |
|
A.85 AUTOMATIC TOOL FOR MLC LEAVES POSITION AND COLLIMATOR ROTATION DETECTION USING EPID IMAGES |
30 |
|
A.86 IMPACT OF AUTO BEAM-OFF AND 4D MODEL AUTOMATIC UPDATE ON TRACKING ACCURACY OF THE VERO SYSTEM |
31 |
|
A.87 COMPARISON OF FIELD-IN-FIELD TANGENTIAL TREATMENT VERSUS THE CONVENTIONAL TREATMENT |
31 |
|
A.88 IMPACT OF THE MLC DELIVERY ERRORS ON PATIENT DOSE FOR IMRT TREATMENTS: A COMPARISON BETWEEN PLANNED DVH AND RECONSTRUCTED DVH BASED ON MLC LOG FILE (DYNALOG) |
31 |
|
A.89 VERIFICATION OF DOSE DISTRIBUTION FROM CCX RU-106 EYE-PLAQUES BY USING A MICRODIAMOND DOSIMETER |
31 |
|
A.90 ACTIVE BREATHING CONTROL (ABC) APPLIED TO LEFT BREAST CANCER (LBC): DOSIMETRIC RESULTS AFTER 50 PATIENTS AT SPEDALI CIVILI OF BRESCIA |
32 |
|
A.91 A TOOL TO CHECK BRACHYTHERAPY TREATMENT TIME: A STATISTICAL APPROACH |
32 |
|
A.92 EPID-BASED IN-VIVO DOSIMETRY FOR PROSTATE CANCER TREATED BY VOLUMETRIC ARC THERAPY: PRELIMINARY CLINICAL RESULTS |
32 |
|
A.93 PATIENT’S BREATHING DURING PROSTATE RADIOTHERAPY SESSIONS: IS IT REALLY A SECOND ORDER EFFECT? |
33 |
|
A.94 DOSIMETRIC IMPACT OF CONTOURING VARIABILITY FOR PROSTATE CANCER PATIENTS UNDERGOING COMBINED CARBON IONS/PHOTONS TREATMENT (AIRC-IG 14300) |
33 |
|
A.95 CLINICAL IMPLEMENTATION OF BREAST IMRT |
33 |
|
A.96 LUNG SABR: A LARGE-SCALE MULTI-INSTITUTIONAL DOSIMETRIC AND RADIOBIOLOGICAL PLANNING COMPARISON |
34 |
|
A.97 IGRT CONE BEAM CT: A METHOD TO EVALUATE PATIENT DOSE |
34 |
|
A.98 PREDICTIVE MODELS FOR RADIO-INDUCED EFFECTS AFTER SRS FOR UVEAL MELANOMA: A MONO-INSTITUTIONAL ANALYSIS |
34 |
|
A.99 QUALITATIVE AND QUANTITATIVE DIFFERENCES IN MULTIPLE HDR BRACHYTHERAPY APPLICATION TO LOCALLY ADVANCED CERVICAL CANCER |
34 |
|
A.100 IN VIVO DOSIMETRY IN 3D CONFORMAL RADIOTHERAPY FOR PROSTATE CANCER WITH GAFCHROMIC® EBT3 FILMS: A FEASIBILITY STUDY |
35 |
|
A.101 OUTPUT FACTORS FOR A LINAC EQUIPPED WITH CIRCULAR CONES: CORRECTION FACTORS DETERMINATION FOR DIFFERENT ACTIVE DETECTORS COMPARED TO GAFCHROMIC FILMS |
35 |
|
A.102 A GEOMETRICAL ANALYSIS OF ACCURACY IMPROVEMENT USING A COUCH 6-DEGREE OF FREEDOM IN SBRT |
35 |
|
A.103 THE ORGAN EQUIVALENT DOSE TO QUANTIFY SECONDARY CANCER INDUCTION IN BREAST AFTER VMAT TREATMENTS |
36 |
|
A.104 A MACHINE LEARNING TOOL FOR RE-PLANNING AND ADAPTIVE RT: A MULTICENTER COHORT INVESTIGATION |
36 |
|
A.105 NEW ERA FOR QA AND VMAT: REAL-TIME MONITOR SYSTEM IN CLINICAL PRACTICE |
36 |
|
A.106 NAL PROTOCOL IMPLEMENTATION AND REDUCTION OF SYSTEMATIC ERRORS IN PATIENT SETUP DURING RADIATION THERAPY |
36 |
|
A.107 CATALYST SYSTEM IN BREAST CANCER RADIATION THERAPY: FEASIBILITY STUDY AND PERFORMANCE ASSESSMENT |
37 |
|
A.108 DOSIMETRIC COMPARISON BETWEEN FOUR IRRADIATION TECHNIQUES FOR BREAST CANCER |
37 |
|
A.109 PRE-TREATMENT DQA USING ARCCHECK FOR CRANIOSPINAL IRRADIATION WITH HELICAL TOMOTHERAPY |
37 |
|
A.110 CLINICAL IMPLICATIONS AFTER A CHANGE IN THE DOSE CALCULATION ALGORITHM IN VMAT TREATMENTS OF NASOPHARYNGEAL TUMORS |
37 |
|
A.111 BLADDER DOSE-SURFACE MAPS CORRELATE WITH ACUTE URINARY TOXICITY AFTER RADIOTHERAPY FOR PROSTATE CANCER: FINAL RESULTS OF A MULTICENTRIC STUDY |
38 |
|
A.112 DOSIMETRIC COMPARISON OF 3D CONFORMAL VS VOLUMETRIC ARC RADIATION THERAPY VS HYBRID 3D/B-VMAT FOR MEDIASTINAL TUMOR |
38 |
|
A.113 DOSE PAINTING BY NUMBERS (DPBN) GUIDED BY DIFFUSION-WEIGHTED MRI APPLIED TO RECURRENT GLIOBLASTOMA (GBM): AN EXPERIMENTAL PROTOCOL OF PHASE I/II |
38 |
|
A.114 PARAMETER INCIDENCE ON GAMMA INDEX FOR IMRT-VMAT PROSTATE TREATMENT PLANS: THE INFLUENCE OF MU AND PTV SHAPE |
39 |
|
A.115 MEDICAL PHYSICIST AND HEALTH TECHNOLOGY ASSESSMENT: ADDED VALUE IN A CASE OF IORT EVALUATION |
39 |
|
A.116 DOSIMETRIC CHARACTERIZATION OF A LASER-DRIVEN ACCELERATION SYSTEM |
39 |
|
A.117 OPTIMIZATION OF BIOLOGICAL DOSE AFTER NOT PLANNED INTERRUPTION IN PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMAS (HNSCC) TREATED BY EBRT |
40 |
|
A.118 EXPERIMENTAL VALIDATION OF AN IBEAM® EVO ELEKTA COUCH MODEL IN PHILIPS PINNACLE3 TPS |
40 |
|
A.119 EVALUATION OF PLANNING TARGET VOLUME MARGINS BY ANALYZING INTRA-FRACTION PATIENT MOVEMENTS DURING STEREOTACTIC BODY RADIATION THERAPY (SBRT) OF LUNG LESIONS |
40 |
|
A.120 EVALUATION OF A COMMERCIAL AUTOMATED INVERSE PLANNING SYSTEM FOR H&N TREATMENTS |
40 |
|
A.121 FILM DOSIMETRY WITH MULTICHANNEL APPROACH FOR PROTON THERAPY PATIENT-SPECIFIC QA |
41 |
|
A.122 VALIDATION OF A METHOD FOR IN-VIVO PROTON RANGE VERIFICATION IN THE TREATMENT OF PEDIATRIC MEDULLOBLASTOMA |
41 |
|
A.123 IN VIVO DOSIMETRY ON 428 PATIENTS WITH BREAST CANCER TREATED WITH INTRAOPERATIVE RADIATION THERAPY IN PRESENCE OF DIFFERENT INTERNAL SHIELDING MATERIALS |
41 |
|
A.124 A PROACTIVE STUDY OF RISK APPLIED TO THE PLANNING PROCESS FOR IMRT/VMAT TREATMENTS |
42 |
|
A.125 FEASIBILITY OF INTRAOPERATIVE RADIOTHERAPY WITH ELECTRONS IN BREAST CANCER PATIENTS WITH CARDIAC DEVICES |
42 |
|
A.126 AN EPID BASED QUALITY ASSURANCE METHOD OF FFF BEAMS ON CONVENTIONAL LINAC |
42 |
|
A.127 VERIFICATION OF A PORT FILM GRATICULE FOR DAILY QUALITY ASSURANCE |
42 |
|
A.128 FORECASTING ALGORITHM TO PREDICT RE-PLANNING IN TOMOTHERAPY: FOLLOW-UP TOXICITY CORRELATION |
43 |
|
A.129 INTRA-FRACTION MOTION IN IMRT, VMAT AND HELICAL TOMOTHERAPY: IN VIVO DOSIMETRY USING TLD AND LEGO PHANTOM |
43 |
|
A.130 SUSCEPTIBLE-INFECTED-SUSCEPTIBLE MODEL APPLIED TO RT TO PREDICT PAROTID GLANDS SHRINKAGE DURING 6 WEEKS OF THERAPY |
43 |
|
A.131 EVALUATION OF DOSE COMING FROM RADIOLOGICAL MONITOR IMAGES TO PACEMAKER IN PATIENT UNDERGOING CYBERKNIFE® TREATMENT |
44 |
|
A.132 IS THE OUTCOME OF PROSTATE CANCER PATIENTS TREATED WITH 3D CONFORMAL RADIOTHERAPY INFLUENCED BY RECTAL/BLADDER PREPARATION? |
44 |
|
A.133 DOSIMETRIC COMPARISON OF EXTERNAL BEAM RADIOTHERAPY WITH 3DCRT, FORWARD-PLANNING IMRT AND VOLUMETRIC ARC THERAPY (VMAT) IN PANCREATIC CANCER |
44 |
|
A.134 MULTICENTER EVALUATION OF THE DOSIMETRIC CHARACTERIZATION OF LINAC SMALL BEAMS USING A PLASTIC SCINTILLATOR DETECTOR |
44 |
|
A.135 STUDY ON THE DOSIMETRY OF LASER ACCELERATED BEAMS FOR FUTURE CLINICAL APPLICATIONS |
45 |
|
A.136 EVALUATION OF SCATTERED RADIATION FROM ELECTRON APPLICATORS IN PATIENT WITH IMPLANTED ELECTRONIC DEVICES |
45 |
|
A.137 PROTOCOL IMPLEMENTATION OF TOTAL MARROW IRRADIATION (TMI) PLUS TOTAL LYMPHOID IRRADIATION (TLI) USING HELICAL TOMOTHERAPY (HT) |
45 |
|
A.138 USING CONE BEAM CT (CBCT) TO DOSE TRACKING |
46 |
|
A.139 DIFFUSION AND SENSITIVITY CHARACTERISTICS OF A CHEMICALLY CROSS-LINKED PVA-FRICKE GEL DOSIMETER |
46 |
|
A.140 ALANINE/ESR DOSIMETRY FOR TOTAL BODY IRRADIATION USING AN ANTHROPOMORPHIC PHANTOM |
46 |
|
A.141 NUCLEAR MAGNETIC RESONANCE RELAXOMETRY AND IMAGING FOR DOSIMETRY WITH AGAROSE FRICKE GEL |
47 |
|
A.142 DOSE VERIFICATION OF VMAT HYPOFRACTIONATED LUNG TREATMENTS IN MOVING PHANTOM |
47 |
|
A.143 INITIAL EXPERIENCE WITH AN ACTIVE BREATHING COORDINATOR DEVICE FOR BREATH HOLD RADIOTHERAPY TREATMENT OF BREAST |
47 |
|
A.144 EVALUATION OF AN INTEGRAL QUALITY MONITOR DEVICE FOR MONITORING REAL-TIME DELIVERY |
47 |
|
A.145 CYBERKNIFE BEAM OUTPUT FACTOR MEASUREMENTS: A MULTI-SITE, MULTI-DETECTOR STUDY |
48 |
|
A.146 VERIFICATION OF THE GEOMETRIC AND DOSIMETRIC ACCURACY OF THE CYBERKNIFE SYNCHRONY SYSTEM |
48 |
|
A.147 DELIVERY QUALITY ASSURANCE FOR CYBERKNIFE TUMOR-TRACKING TREATMENTS |
48 |
|
A.148 QUALITY ASSURANCE TESTS FOR BRACHYTHERAPY TREATMENTS USING LEIPZIG APPLICATORS |
49 |
|
A.149 STUDY OF DOSIMETRIC IMPROVEMENT IN LUNG SBRT USING A 6-DEGREE OF FREEDOM COUCH IN IGRT |
49 |
|
A.150 PROSTATE MOVEMENTS ANALYSIS DURING RADIOTHERAPY USING VOLUMETRIC INTRAPROSTATIC GOLD COILS INFORMATION |
49 |
|
A.151 DOSIMETRIC AND PRECLINICAL RESULTS OF SMALL ANIMAL IRRADIATION BY USING TOMOTHERAPY |
50 |
|
A.152 INNOVATIVE SOLUTION FOR IORT BREAST TREATMENT: AN ON-LINE IN VIVO DOSIMETER INTEGRATED IN THE RADIATION PROTECTION DISC |
50 |
|
A.153 BOLUS IN VMAT BREAST TREATMENT |
50 |
|
A.154 ANALYSIS OF SETUP UNCERTAINTIES AND CHOICE OF WIDTH OF GATING WINDOW FOR LEFT-SIDED BREAST TREATMENT DURING DEEP INSPIRATION BREATH-HOLD (DIBH) |
50 |
|
A.155 INFRARED-GUIDED PATIENT SETUP FOR BREAST CANCER PATIENTS: COMPARISON WITH CBCT |
51 |
|
A.156 TOWARD THE DEFINITION OF A DOSIMETER RELATED GAMMA METRIC TO IDENTIFY UNACCEPTABLE VMAT PLANS |
51 |
|
A.157 PRELIMINARY STUDY FOR COMPARISON BETWEEN TWO TREATMENT PLANNING SYSTEMS FOR VOLUMETRIC MODULATED ARC THERAPY |
51 |
|
A.158 A METHOD TO DEFINE ISODOSE-BASED STRUCTURES IN DOSE PAINTING TREATMENT OPTIMIZATION OF GLIOBLASTOMA MULTIFORME TUMORS (GBM) |
52 |
|
A.159 A FEASIBILITY STUDY OF TOMOTHERAPY DOSE PAINTING HYPOFRACTIONATED TREATMENTS ON GLIOBLASTOMA MULTIFORME (GBM) GUIDED BY MRI |
52 |
|
A.160 COMMISSIONING AND IMPLEMENTATION OF DOSIMETRY CHECK WITH TRUEBEAM FFF BEAMS AND NEW DMI-EPID |
52 |
|
A.161 NEUTRON ACTIVATION DETECTORS FOR CLINICAL DOSIMETRY IN EXTERNAL BEAM RADIATION TREATMENTS |
53 |
|
A.162 MOVING TARGET IN TOMOTHERAPY TREATMENT: A PHANTOM STUDY |
53 |
|
A.163 SLICED MARY: A DEFORMABLE PHANTOM FOR THE VALIDATION OF SET-UP BASED ON SURFACE IMAGING IN RADIOTHERAPY TREATMENTS |
53 |
|
A.164 ADAM: A 3D PRINTED BREATHING PHANTOM FOR END TO END TESTS ON RT TREATMENTS |
53 |
|
A.165 COMMISSIONING OF VOLUMETRIC MODULATED ARC THERAPY AND PATIENT QA WITH OCTAVIUS 2D ARRAY AND GAFCHROMIC EBT3 FILMS |
54 |
|
A.166 CLINICAL AND DOSE PREDICTORS FOR THE INCIDENCE OF LATE URINARY SYMPTOMS AFTER RADICAL RADIOTHERAPY FOR PROSTATE CANCER |
54 |
|
A.167 DOSE UNCERTAINTIES DUE TO INTER-FRACTIONAL ANATOMICAL CHANGES FOR CARBON ION THERAPY IN THE ABDOMINAL REGION |
54 |
|
A.168 DOSIMETRIC ASSESSMENT OF 3D-PRINTED APPLICATORS FOR HIGH DOSE RATE BRACHYTHERAPY |
55 |
|
A.169 RADIOBIOLOGICAL ANALYSIS FOR EVALUATION OF SIB HYPOFRACTIONATED TREATMENT IN H&N DISEASE |
55 |
|
A.170 DEFORMABLE REGISTRATION AND CONTOURING PROPAGATION OF THE BOWEL LOOPS ON DAILY MVCTS: EVALUATION OF INTER-OBSERVER VARIATIONS AND THE IMPACT ON DVHS |
55 |
|
A.171 NEW APPROACH TO BRAIN METASTASES TREATMENT |
55 |
|
A.172 EVALUATION OF THE COMPASS SYSTEM FOR DOSIMETRIC PRETREATMENT VERIFICATION OF VMAT PLANS: PROPOSAL OF A CONFORMITY INDICATOR |
56 |
|
A.173 MULTICENTRE RESULTS OF EPID-BASED IN-VIVO DOSIMETRY |
56 |
|
A.174 A QUANTITATIVE TEST TO EVALUATE THE PERFORMANCE OF THE MULTILEAF COLLIMATOR |
56 |
|
A.175 PERSPECTIVES OF USING AN INTEGRAL QUANTITY FOR REFERENCE DOSIMETRY OF SMALL PHOTON BEAMS |
57 |
|
A.176 CVD DIAMOND SCHOTTKY PHOTODIODE IN AWIRELESS CONFIGURATION FOR IN-VIVO DOSIMETRY APPLICATION |
57 |
|
A.177 ESTABLISHMENT AT ENEA-INMRI OF A NEW ABSORBED DOSE TO WATER PRIMARY STANDARD FOR MEDIUM-ENERGY X-RAY BEAMS |
57 |
|
A.178 THE INSIDE PROJECT FOR THE ON-LINE VERIFICATION OF HADRONTHERAPY TREATMENTS: TEST RESULTS WITH A CLINICAL PROTON BEAM |
58 |
|
A.179 USING ANATOMIC AND METABOLIC IMAGING IN STEREOTACTIC RADIO NEURO-SURGERY TREATMENTS |
58 |
|
A.180 PRELIMINARY DOSIMETRIC STUDY FOR PRECLINICAL SMALL ANIMAL HADRONTHERAPY |
58 |
|
A.181 IN-SILICO IMPLEMENTATION OF MRI-60CO BASED RT: A DOSIMETRICAL COMPARISON WITH RECTAL CANCER (SIMBAD) |
58 |
|
A.182 MONTE CARLO DOSE CALCULATION OF VIEWRAY HYBRID MRI-CO60 RADIOTHERAPY SYSTEM: A REPEATABILITY STUDY |
59 |
|
A.183 GAFCHROMIC EBT3 CALIBRATION: A NEW CURVE TYPE REDUCING THE DEPENDENCE ON FILMS LOT |
59 |
|
A.184 DIGITAL CAMERA SYSTEM AS A CHEAP AND EASY PREDICTION TOOL OF SKIN TOXICITY IN BREAST RADIOTHERAPY: VALIDATION AND FUTURE PERSPECTIVES |
59 |
|
A.185 VMAT PATIENT SPECIFIC QA: CHARACTERIZATION AND VALIDATION OF THE COMPASS SYSTEM |
60 |
|
A.186 SMALL FIELD DOSIMETRY FOR VMAT IMPLEMENTATION: A MULTIDETECTOR STUDY |
60 |
|
A.187 CHARACTERIZATION OF EXRADIN A26 MICRO IONIZATION CHAMBER IN UNFLATTENED PHOTON BEAMS |
60 |
|
A.188 PRELIMINARY INVESTIGATIONS ON THE USE OF PTW T60020 DOSIMETRY DIODE PR IN CLINICAL PROTON BEAMS AT CATANA PROTONTHERAPY FACILITY |
60 |
|
A.189 EARLY PREDICTION OF INDIVIDUAL RESPONSE IN NEO-ADJUVANT ADAPTIVE RADIOCHEMOTHERAPY FOR RECTAL CANCER |
61 |
|
A.190 A COMPARISON BETWEEN STATIC AND HELICAL CALIBRATION OF THE NEW OCTAVIUS DETECTOR 729 IN TOMOTHERAPY |
61 |
|
A.191 CHARACTERIZATION OF A NEW STEREOTACTIC DIODE UNDER FLATTENING FILTER FREE BEAMS DOWN TO SMALL FIELDS |
61 |
|
A.192 A PRELIMINARY DOSIMETRIC STUDY TO VALIDATE MULTI-SEGMENT PLAN (FIELD IN FIELD) FOR BREAST IRRADIATION USING IN VIVO DOSIMETRY (IVD) |
62 |
|
A.193 INTRAFRACTION BREAST DISPLACEMENTS DURING HELICAL TOMOTHERAPY |
62 |
|
A.194 DOSIMETRIC PROPERTIES OF 3D-PRINTED FLAT BOLUS FOR EXTERNAL RADIOTHERAPY |
62 |
|
A.195 THE USE OF A REDUNDANT INDEPENDENT CALCULATION SOFTWARE IN THE EXTRA-CRANIAL STEREOTACTIC SMALL FIELD RADIOTHERAPY AS PART OF QUALITY ASSURANCE PROGRAM |
63 |
|
A.196 FIRST CLINICAL SYSTEM FOR FULLY AUTOMATED PLANNING FOR NONCOPLANAR CYBERKNIFE: COMPARISON WITH COPLANAR VMAT FOR PROSTATE SBRT |
63 |
|
A.197 CLINICAL SUPPORT IN RADIATION THERAPY SCENARIOS: MR BRAIN TUMOR SEGMENTATION USING AN UNSUPERVISED FUZZY C-MEANS CLUSTERING TECHNIQUE |
63 |
|
A.198 DOSIMETRIC CHARACTERIZATION OF A COMMERCIAL 2-D SCINTILLATION DETECTOR FOR QUALITY ASSURANCE TESTS IN SCANNED PROTON AND CARBON ION BEAMS |
63 |
|
A.199 ASSESSMENT OF DOSIMETRIC IMPACT OF CARBON FIBER STABILIZATION DEVICES FOR POSTOPERATIVE PARTICLE THERAPY |
64 |
|
A.200 SMALL FIELD OUTPUT FACTOR EVALUATION WITH A MICRODIAMOND DETECTOR OVER 30 ITALIAN CENTERS |
64 |
|
A.201 DOSIMETRIC BENEFITS AND REPRODUCIBILITY OF DIBH TECNIQUE GUIDED BY AN OPTICAL SYSTEM |
64 |
|
A.202 DOSE PROFILES OF LOW ENERGY BEAMS FOR DOSIMETER CALIBRATION |
65 |
|
A.203 MODELING OF COUCH TRANSMISSION IN THE RAYSTATION TREATMENT PLANNING SYSTEM |
65 |
|
A.204 RAPIDARC PROSTATE TREATMENTS: RELATION BETWEEN DOSIMETRIC ACCEPTABILITY AND PLAN QUALITY |
65 |
|
A.205 ADVANCES IN KILOVOLTAGE X-RAY BEAM DOSIMETRY BY MONTE CARLO CALCULATIONS AND MULTIPLE DETECTOR INTERCOMPARISON |
65 |
|
A.206 A NEW MEASURING SYSTEM OF MAMMARY GLAND THICKNESS PRIOR TO INTRAOPERATIVE RADIOTHERAPY WITH ELECTRON BEAMS (IOERT) IMPROVES DOSIMETRIC TREATMENT ACCURACY |
66 |
|
A.207 EVALUATION OF CT-BASED FEATURES AND ADC VALUES TO ASSESS TUMOR CONTROL ON CERVICAL LYMPH NODES TREATED WITH CHEMORADIOTHERAPY |
66 |
|
A.208 BOWEL DOSE-VOLUME PREDICTORS OF DIARRHEA IN PATIENTS TREATED WITH POST-PROSTATECTOMY WHOLE-PELVIS IMRT |
66 |
|
A.209 SPINAL LESION TREATMENT USING THE CYBERKNIFE: A SINGLE FRACTION RADIOSURGICAL TECHNIQUE |
67 |
|
A.210 INNOVATIVE APPROACH IN IORT SARCOMA ASSESSMENT USING A DEDICATED TREATMENT PLANNING SYSTEM |
67 |
|
A.211 COMPARISON OF THREE DIFFERENT SYSTEMS FOR GAMMA INDEX EVALUATION IN IMRT TREATMENTS |
67 |
|
A.212 A NEW METHOD TO CALIBRATE GAFCHROMIC® EBT3 FILMS FOR ROUTINE QUALITY CONTROL IN RADIOTHERAPY PHOTON BEAMS |
68 |
|
A.213 AN IN-HOUSE SOFTWARE TO CREATE SYNTHETIC-CT BASED ON MRI |
68 |
|
A.214 VALIDATION OF A NEW COMMERCIAL OPTIMIZATION TOOL FOR VMAT TREATMENT PLANNING |
68 |
|
A.215 BIOLOGICAL TARGET VOLUME SEGMENTATION FOR RADIOTHERAPY TREATMENT PLANNING |
69 |
|
A.216 A NEW 3D RADIOTHERAPY TECHNIQUE REDUCES SKIN TOXICITY FOR LARGE BREAST AND/OR HIGH BMI PATIENTS |
69 |
|
A.217 IMPLEMENTATION OF A NEW STRATEGY FOR DOSE TRACKING AND OF NOVEL RADIOBIOLOGICAL MODELS FOR ADAPTIVE RADIOTHERAPY |
69 |
|
A.218 EVALUATION OF THE AUTOSEGMENTATION TOOL OF NORMAL TISSUE STRUCTURES IN PROSTATE CANCER: A MULTICENTRIC STUDY |
69 |
|
A.219 INTRA- OR PERIPROSTATIC CALCIFICATIONS AS NATURAL FIDUCIAL MARKERS FOR PROSTATE LOCALIZATION IN IMAGE-GUIDED RADIOTHERAPY |
70 |
|
A.220 IN VIVO DOSIMETRY WITH GAFCHROMIC FILMS DURING INTRAOPERATIVE RADIATION THERAPY (IORT): A GOOD PRACTICE FOR QUALITY ASSURANCE |
70 |
|
A.221 CHARACTERIZATION OF A BIDIMENSIONAL POLYCRYSTALLINE CVD DIAMOND DOSIMETER WITH PHOTON BEAMS |
70 |
|
A.222 MULTICENTRE STUDY OF RELATIVE DOSIMETRY MEASUREMENTS USING RAZOR NEW SILICON DIODE |
71 |
|
A.223 BEAM DELIVERY CHECK AND IN-VIVO DOSIMETRY DURING BREAST RADIOTHERAPY TREATMENT |
71 |
|
A.224 QUALITY ASSURANCE TOOLS FOR RISK MANAGEMENT |
71 |
|
A.225 CHARACTERISTICS AND CRITICALITIES OF OCTAVIUS-4D DETECTOR SYSTEM FOR IMRT AND RAPIDARC PLAN VERIFICATION |
72 |
|
A.226 COMPARISON OF DOSIMETRIC SYSTEMS IN RADIOTHERAPY PLAN VERIFICATION |
72 |
|
A.227 NEW EXPERIENCE WITH BREAST VOLUMETRIC MODULATION ARC THERAPY (VMAT) REALIZED WITH TRILOGY LINAC: COMPARISON WITH TOMOTHERAPY, PROS AND CONS |
72 |
|
A.228 MONTE CARLO-CORRECTED GTV DOSE PRESCRIPTION ON LUNG TUMORS TREATED WITH CYBERKNIFE: A POSSIBLE RECIPE |
72 |
|
A.229 A VERSATILE ASYMMETRIC COLLIMATION SYSTEM FOR CLINICAL USE IN EXTERNAL ELECTRON BEAM RADIOTHERAPY WITH ELEKTA’S LINAC |
73 |
|
A.230 COMMISSIONING OF FLATTENING FILTER FREE BEAM FOR STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) LUNG TREATMENTS |
73 |
|
A.231 STUDY OF THE DOSE DELIVERY SYSTEM INACCURACIES AND THEIR IMPACT ON THE DOSE DISTRIBUTION DURING THE FIRST YEARS OF THE CNAO CLINICAL ACTIVITY |
73 |
|
A.232 A NATIONAL MULTI-INSTITUTIONAL STUDY TO ASSESS DOSIMETRIC CONSISTENCY IN TREATMENT PLANNING OF PROSTATE STEREOTACTIC BODY RADIATION THERAPY (SBRT) |
74 |
|
A.233 3D EVALUATION OF PRE-TREATMENT AND IN-VIVO EPID-BASED DOSIMETRY IN VMAT PROSTATE TREATMENTS: INITIAL EXPERIENCE WITH A COMMERCIAL SOFTWARE |
74 |
|
A.234 EBT3 AND MICRODIAMOND FOR SUPERFICIAL DOSE MEASUREMENTS UNDER A TOMOTHERAPY H&N IRRADIATION |
74 |
|
A.235 IN-HOUSE IMAGEJ PLUG-IN FOR THE QUALITY ASSURANCE OF DYNAMIC MULTI LEAF COLLIMATOR |
75 |
|
A.236 VMAT PLANNING APPROACH TO AVOID SUPERFICIAL UNDERDOSAGE FOR ACCELERATED PARTIAL BREAST IRRADIATION |
75 |
|
Radiodiagnostics and Interventional Radiology |
76 |
|
B.237 CT AND MRI: A UNIQUE PHANTOM FOR QUALITY CONTROLS |
76 |
|
B.238 EVALUATION OF RADIATION DOSE INCREMENT IN CONTRAST-ENHANCED CT FOR DIFFERENT X-RAY BEAM QUALITIES |
76 |
|
B.239 QUANTITATIVE ASSESSMENT OF NOISE AND SPATIAL RESOLUTION PROPERTIES OF ASIR-RECONSTRUCTED CT IMAGES AT DIFFERENT PERCENTAGES OF RECONSTRUCTION |
76 |
|
B.240 DOSIMETRIC AND QUALITATIVE EVALUATION OF CT LONGITUDINAL AUTOMATIC TUBE CURRENT MODULATION USING IN-HOUSE PHANTOMS |
77 |
|
B.241 MONITORING OF DATA OF EXPOSURE OF COMPUTED TOMOGRAPHY EXAMINATIONS BY ANALYSIS OF RADIATION DOSE STRUCTURED REPORTS |
77 |
|
B.242 A NOVEL IMAGEJ MACRO FOR CATPHAN LOW CONTRAST MODULE ANALYSIS: PRELIMINARY RESULTS |
77 |
|
B.243 DUAL ENERGY CT IMAGING FOR BONE MARROW EDEMA DETECTION |
78 |
|
B.244 MONTE CARLO (MC) CODE APPLICATION TO MAMMOGRAPHY: EVALUATION OF THE COEFFICIENTS FOR THE ESTIMATION OF THE AVERAGE GLANDULAR DOSE (AGD) |
78 |
|
B.245 PATIENT DOSE EVALUATION IN DIGITAL BREAST TOMOSYNTHESIS THROUGH A MATLAB SCRIPT |
78 |
|
B.246 APPLICATION OF THE EUREF PROTOCOL FOR ACCEPTANCE TEST OF THREE DIGITAL BREAST TOMOSYNTHESIS SYSTEMS |
78 |
|
B.247 ORGAN DOSES AND CANCER LIFETIME ATTRIBUTABLE RISK EVALUATIONS IN SCOLIOSIS EXAMINATIONS WITH THE EOS IMAGING SYSTEM |
79 |
|
B.248 STAFF DOSE REDUCTION DURING CORONARY ANGIOGRAPHIES PROCEDURES USING RADIO-ABSORBING SURGICAL DRAPES |
79 |
|
B.249 ESTIMATION OF DIAGNOSTIC LEVELS (DLS) IN CT AND X-RAY PROCEDURES: IMPORTANCE OF PATIENT SAMPLE |
79 |
|
B.250 GAMMA-TOOLS: A MULTIPURPOSE PHANTOM FOR QUALITY ASSURANCE IN GAMMA KNIFE STEREOTACTIC RADIOSURGERY TREATMENTS |
80 |
|
B.251 CLIMATE CHANGE IMPACTS ON RADIOLOGICAL RISK MANAGEMENT IN HOSPITALS |
80 |
|
B.252 PATIENT RADIATION DOSE IN INTERVENTIONAL PROCEDURES FOR INTRACRANIAL ANEURYSMS: FIRST RESULTS OF A MULTI-CENTER EXPERIENCE |
80 |
|
B.253 ITERATIVE RECONSTRUCTION COMPARISON IN CT: MODEL BASED (MBIRVEO), ADAPTIVE STATISTICAL (ASIR) AND NEW ADAPTIVE STATISTICAL ITERATIVE (ASIR-V) |
80 |
|
B.254 RADIOLOGIC IMAGING OF THE NEWBORN INSIDE THE INCUBATOR. PART 2: RADIATION DOSE AND IMAGE QUALITY |
81 |
|
B.255 RADIOLOGIC IMAGING OF THE NEWBORN INSIDE THE INCUBATOR. PART 3: RISK ESTIMATION |
81 |
|
B.256 PRELIMINARY EVALUATION OF THE ABSORBED FETAL DOSE ASSOCIATED WITH PRE-DELIVERY UTERINE ARTERIES EMBOLIZATION |
81 |
|
B.257 ANALYSIS OF DOSIMETRIC DATA FROM CT EXAMINATION COLLECTED WITH RDIM SYSTEM, TERRITORIAL AREA OF RAVENNA, AUSL DELLA ROMAGNA |
81 |
|
B.258 TEXTURE ANALYSIS IN CT AND PET: A PHANTOM STUDY FOR FEATURES VARIABILITY ASSESSMENT |
82 |
|
B.259 IMAGE QUALITY IN DIGITAL BREAST TOMOSYNTHESIS: A PHANTOM ASSESSMENT |
82 |
|
B.260 OPTIMISATION OF PAEDIATRIC FULL SPINE EXAMINATION: THE EXPERIENCE OF CARLO POMA GENERAL HOSPITAL IN MANTOVA |
82 |
|
B.261 STANDARDIZED EVALUATION OF CT IMAGE QUALITY: A COMPARISON BETWEEN THREE WIDESPREAD SOFTWARE PACKAGES FOR AUTOMATED CATPHAN ANALYSIS |
83 |
|
B.262 THE RECENTLY INTRODUCED STANDARDIZED EXPOSURE INDEX CAN BE A USEFUL TOOL FOR AEC PERFORMANCE CONTROLS? |
83 |
|
B.263 LOCAL REFERENCE LEVELS FOR INTERVENTIONAL RADIOLOGY USING A DOSE TRACKING APPLICATION: PRELIMINARY RESULTS |
83 |
|
B.264 DEFINITION OF LOCAL DOSE REFERENCE LEVELS IN INTERVENTIONAL CARDIOLOGY USING A DOSE TRACKING SYSTEM |
83 |
|
B.265 HOW TO DEFINE LOCAL DIAGNOSTIC REFERENCE LEVELS FOR CT, MG AND XA USING A DOSE TRACKING SOFTWARE |
84 |
|
B.266 EVALUATION OF THE VOLUMETRIC DOSE IN DIGITAL BREAST TOMOSYNTHESIS |
84 |
|
B.267 RETROSPECTIVE DOSE EVALUATION IN ADULTS UNDERGOING RECURRING CT EXAMINATIONS: LAST FIVE YEARS EXPERIENCE IN OUR INSTITUTION |
84 |
|
B.268 PROJECT OF AN AUTOMATIC SYSTEM FOR TRADITIONAL RADIOLOGY EQUIPMENTS AND IMAGE DETECTORS QUALITY CONTROLS |
84 |
|
B.269 RETROSPECTIVE ANALYSIS OF ANGIOGRAPHIC PROCEDURES: DOSIMETRIC EVALUATION |
85 |
|
B.270 INTERVENTIONAL CARDIOLOGY: COMPARISON OF DATA FROM THREE CENTERS WITH SIMILAR TECHNOLOGY |
85 |
|
B.271 GUI SOFTWARE FOR AUTOMATIC DQE CALCULATION IN DIGITAL RADIOGRAPHY |
85 |
|
B.272 DENTAL HYBRID CONE BEAM CT EFFECTIVE DOSES AND PATIENT RADIOLOGICAL REPORT |
86 |
|
B.273 EVALUATION OF THE ACTUAL PERCEPTION OF MEDICAL IMAGES INFORMATIVE CONTENT BY VARYING MEDICAL DISPLAYS PERFORMANCES |
86 |
|
B.274 A NOVEL COMPUTERIZED METHOD FOR QUALITY ASSURANCE OF MEDICAL ULTRASOUND PROBES |
86 |
|
B.275 CONE BEAM COMPUTED TOMOGRAPHY (CBCT) CHARACTERIZATION FOR IN-VIVO CANCELLOUS BONE STRUCTURAL MEASUREMENTS |
86 |
|
B.276 PERFORMANCE EVALUATION OF DIFFERENT DIGITAL BREAST TOMOSYNTHESIS SYSTEMS: DOSE AND IMAGE QUALITY ASSESSMENT |
87 |
|
B.277 ESTIMATE ORGAN DOSE FROM CT EXAMINATION: A SOFTWARE COMPARISON |
87 |
|
B.278 HEALTH DOSE ASSESSMENT OR HEALTH TECHNOLOGY ASSESSMENT? |
87 |
|
B.279 EFFECT OF THE PEDIATRIC PATIENT POSITIONING AND MANAGEMENT ON CT AEC |
88 |
|
B.280 PATIENT CT DOSIMETRY: USE OF THE DICOMSR PROTOCOL FOR CALCULATION AND MONITORING OF DRL AND RELEVANT PARAMETERS |
88 |
|
B.281 THE SYRMA-CT PROJECT FOR BREAST COMPUTED TOMOGRAPHY WITH SYNCHROTRON RADIATION: IMAGE QUALITY AND DOSE EVALUATION |
88 |
|
B.282 CT-BASED MONITORING OF MICROWAVE THERMAL ABLATION |
88 |
|
B.283 PATIENT DOSE IN UTERINE ARTERY EMBOLIZATION (UAE) FOR FIBROIDS: A RETROSPECTIVE STUDY BASED ON DATA REGISTERED IN RIS/PACS |
89 |
|
B.284 THE USE OF IVC FILTERS IN PREGNANCY: DOSIMETRIC CONSIDERATIONS ON CLINICAL CASES |
89 |
|
B.285 EFFECTIVENESS OF A RADIOLOGIC TECHNOLOGIST INTERNAL AUDIT |
89 |
|
B.286 CT IMAGE QUALITY ASSESSMENT BY CHANNELIZED HOTELLING OBSERVER (CHO): METHOD AND IMPLEMENTATION |
89 |
|
B.287 SYNTHETIC 2D RECONSTRUCTIONS OF DIGITAL BREAST TOMOSYNTHESIS: AN ATTEMPT OF OBJECTIVE IMAGE QUALITY ASSESSMENT |
90 |
|
B.288 A NEW METHOD FOR THE DIRECT EVALUATION OF DOSIMETRIC PARAMETERS FOR PEDIATRIC PATIENTS IN HIGH PITCH CT SCANS OVERCOMING AAPM RTP111 |
90 |
|
B.289 RADIATION DOSE TRACKING: EXPERIENCE IN CLINICAL MAMMOGRAPHY |
90 |
|
B.290 DOSE REDUCTION IN PEDIATRIC CT CLINICAL INVESTIGATIONS: THE IMPACT OF THE ADAPTIVE STATISTICAL ITERATIVE RECONSTRUCTION ALGORITHM (ASIR) |
91 |
|
B.291 DEFINITION OF LOCAL REFERENCE DIAGNOSTIC LEVELS FOR CT WITH A DOSE-TRACKING SOFTWARE |
91 |
|
B.292 DESIGN AND IMPLEMENTATION OF AN IT MANAGEMENT SYSTEM FOR A MEDICAL PHYSICS DEPARTMENT (MPD) ACTIVITY WORKFLOWS |
91 |
|
B.293 A PROPOSAL OF MAMMOGRAPHY QC-RELATED INDICATOR FOR HTA EVALUATION |
91 |
|
B.294 MULTI HOSPITAL EXPERIENCES OF RADIATION DOSE INDEX MONITORING |
92 |
|
B.295 THREE YEARS OF EXPERIENCE WITH DOSE REDUCTION BY MEANS OF ITERATIVE RECONSTRUCTION ALGORITHM AVAILABLE ON CT SIEMENS SOMATOM DEFINITION FLASH |
92 |
|
B.296 ITERATIVE METHOD FOR CT SYSTEM: DOSE REDUCTION AND QUANTITATIVE ANALYSIS OF IMAGE QUALITY IMPROVEMENT |
92 |
|
B.297 EVALUATION OF DIAGNOSTIC REFERENCE LEVELS FOR ANGIOGRAPHY SYSTEM USING A RADIATION DOSE MONITORING SYSTEM |
93 |
|
B.298 COMPARISON OF TWO RADIATION DOSE MONITORING SYSTEMS |
93 |
|
B.299 FOLLOW-UP OF RADIATION SKIN INJURIES IN PATIENTS AFTER FLUOROSCOPICALLY-GUIDED INTERVENTIONAL PROCEDURES: A PRELIMINARY STUDY |
93 |
|
B.300 CBCT DOSE INDICATORS: EVALUATION OF DIFFERENT APPROACHES AND CORRELATION WITH PATIENT DOSE |
93 |
|
B.301 EFFECTIVENESS EVALUATIONS OF AN ORGAN BASED MODULATION SYSTEM FOR COMPUTED TOMOGRAPHY |
94 |
|
B.302 USE OF A COMMERCIAL SOFTWARE TO MANAGE DOSES FROM RADIOLOGICAL PROCEDURES IN A MULTI-SITE ENVIRONMENT: PRESENTATION AND EARLY EXPERIENCE OF A PROJECT FROM AIFM |
94 |
|
B.303 CT IMAGE QUALITY RECONSTRUCTED BY ITERATIVE ALGORITHMS: IS IT TIME TO CHANGE STANDARD ANALYSIS METHODS? |
94 |
|
B.304 ANALYSIS ON PHANTOM IMAGES BETWEEN 2D SYNTHESIZED MAMMOGRAPHY (SM) FROM DIGITAL BREAST TOMOSYNTHESIS (DBT) AND FLAT FIELD MAMMOGRAPHY (FFDM) |
95 |
|
B.305 EVALUATION OF OPERATOR AND PATIENT DOSE DURING INTERVENTIONAL CARDIOLOGY PROCEDURES |
95 |
|
B.306 IMAGE QUALITY IN SYNCHROTRON RADIATION BREAST CT |
95 |
|
B.307 PERSONNEL REAL TIME DOSIMETRY IN INTERVENTIONAL RADIOLOGY |
95 |
|
B.308 MEDICAL DEVICE EVALUATION FOR OPERATORS’ RADIATION PROTECTION IN ANGIOGRAPHIC PROCEDURES OF CHRONIC TOTAL OCCLUSION |
96 |
|
B.309 COMPARISON AMONG THREE DIFFERENT APPROACHES FOR LOW CONTRAST DETECTABILITY EVALUATION IN DIGITAL RADIOGRAPHY |
96 |
|
B.310 LOW CONTRAST DETECTABILITY IN DIGITAL MAMMOGRAPHY: COMPARISON BETWEEN TWO SYSTEMS THROUGH A STATISTICAL METHOD |
96 |
|
B.311 EVALUATION OF CT RADIATION PROFILE WIDTH WITH GAFCHROMIC® XR-QA2 FILMS |
97 |
|
B.312 EVALUATION OF THE EFFECTIVE RESOLUTION OF AN OPTICAL FLATBED SCANNER FOR RADIOCHROMIC FILMS ANALYSIS |
97 |
|
B.313 IMPLEMENTATION OF EUREF QUALITY CONTROL PROTOCOL IN DIGITAL BREAST TOMOSYNTHESIS (DBT) |
97 |
|
B.314 SIZE-SPECIFIC, SCANNER-INDEPENDENT ORGAN DOSE ESTIMATES IN MULTI-SLICE ABDOMINAL CT EXAMINATIONS OF OVERWEIGHT AND OBESE PATIENTS |
97 |
|
B.315 CT IMAGE QUALITY ASSESSMENT BY A CHANNELIZED HOTELLING OBSERVER (CHO): APPLICATION TO PROTOCOL OPTIMIZATION |
98 |
|
B.316 EVALUATION OF TECHNOLOGICAL INNOVATIONS IN STORAGE AND DISTRIBUTION OF RADIOLOGICAL DATA |
98 |
|
B.317 DOSE MANAGEMENT PROGRAM: ONE YEAR RESULTS |
98 |
|
B.318 CLINICAL VALIDATION OF THE M5L LUNG COMPUTER-ASSISTED DETECTION SYSTEM |
99 |
|
B.319 ABSTRACT WITHDRAWN |
99 |
|
B.320 PATIENT-SIZE SPECIFIC EFFECTIVE DOSE ESTIMATION USING SSDE IN ABDOMEN AND CHEST CT EXAMS |
99 |
|
B.321 X-RAY TRANSMISSION EVALUATION OF LEAD-FREE PROTECTIVE APRONS |
99 |
|
B.322 A NEW METHOD FOR THE ANATOMICAL DISTRICT RECOGNITION (ADR) IN CT IMAGES |
100 |
|
B.323 PATIENT RADIATION DOSE IN INTERVENTIONAL CARDIOLOGY PROCEDURES PERFORMED IN MODENA LOCAL HEALTH UNIT |
100 |
|
B.324 DIAGNOSTIC RADIATION DOSE IN ADULT TRAUMA PATIENTS: A SURVEY PERFORMED AT MODENA LOCAL HEALTH UNIT |
100 |
|
B.325 EFFECT OF DIFFERENT FRAME RATES ON LOW CONTRAST DETECTABILITY IN DIGITAL ANGIOGRAPHY |
100 |
|
B.326 LOW CONTRAST DETECTABILITY ASSESSMENT THROUGH A STATISTICAL METHOD: HOMEMADE SOFTWARE AND DEDICATED PHANTOM |
101 |
|
B.327 MULTICENTRIC EXPERIENCE OF DOSE MONITORING FROM MAMMOGRAPHY SYSTEMS USING A COMMERCIAL DOSE REGISTRATION SOFTWARE |
101 |
|
B.328 VIRTUAL MONOENERGETIC IMAGES ON DUAL ENERGY CT: AN IN PHANTOM COMPARISON OF HU ACCURACY IN TWO DIFFERENT SCANNERS |
101 |
|
Developments in Nuclear Medicine |
102 |
|
C.329 IN VIVO SMALL ANIMALS BETA DETECTION: A MONTE CARLO FEASIBILITY STUDY FROM BETA TO CERENKOV LUMINESCENCE IMAGING |
102 |
|
C.330 RADIOBIOLOGICAL ALPHA PARAMETER ESTIMATE FOR A PERSONALIZED 90Y MICROSPHERE TREATMENT OF HEPATO- AND CHOLANGIOCARCINOMA |
102 |
|
C.331 APPLICATION OF STANDARDIZED PROCEDURE ENHANCES RELIABILITY OF SUV DATA IN PET/CT STUDIES |
102 |
|
C.332 IMPACT OF UPTAKE TIME IN PHYSIOLOGICAL COMPARTMENTS FOR PET/CT EXAMINATION |
102 |
|
C.333 APPLICATION OF LIDEA (LIVER DETECTION ALGORITHM) FOR PET/CT SCANS |
103 |
|
C.334 DEPTH-OF-INTERACTION DISCRIMINATION TO CORRECT PARALLAX ERROR IN HIGH RESOLUTION PET |
103 |
|
C.335 GEOMETRY VARIABILITY IN THE MEASUREMENT OF GAMMA, BETA AND ALPHA EMITTERS IN RADIONUCLIDE CALIBRATORS |
103 |
|
C.336 PERFORMANCE CHARACTERISTICS OF BIOGRAPH MCT TOF-PET/CT SCANNER |
104 |
|
C.337 AUTOMATIC GTV CONTOURING APPLYING ANOMALY DETECTION ALGORITHM ON DYNAMIC FDG PET IMAGES |
104 |
|
C.338 BREATHING MOTION CORRECTION IN DOSIMETRY OF LIVER LESION BASED ON 90Y-PET/CT IMAGING |
104 |
|
C.339 THE IMPACT OF EANM (2013) FORMALISM FOR RADIOIODINE DOSIMETRY IN HYPERTHYROIDISM DISEASE: A COMPARATIVE EVALUATION OF THERAPEUTIC ACTIVITY |
104 |
|
C.340 CHARACTERIZATION OF AN INTRAOPERATIVE GAMMA SYSTEM |
105 |
|
C.341 RADIATION PROTECTION IMPACT OF RADIOIODINE THERAPY FOR HYPERTHYROIDISM AFTER A PATIENT SPECIFIC DOSIMETRIC STUDY |
105 |
|
C.342 STUDY OF INTER-FRACTION VARIABILITY OF ABSORBED DOSE TO BONE METASTASES AND FOLLOW-UP FOR A PATIENT WHO UNDERWENT 223RA-DICHLORIDE THERAPY |
105 |
|
C.343 LESIONS DOSIMETRY FOR 223RA THERAPY OF BONE METASTASES FROM CASTRATION-RESISTANT PROSTATE CANCER |
106 |
|
C.344 PET SCANNER CLINICAL TRIAL QUALIFICATION WITH 68GE-FILLED NEMA/IEC IMAGE QUALITY PHANTOM OUTPERFORMS WITH RESPECT TO 18F |
106 |
|
C.345 TRULY DOSIMETRIC TREATMENT PLANNING WITH 99M-TC MAA SPECT PROLONGED OVERALL SURVIVAL IN RADIOEMBOLIZATION OF HEPATOCARCINOMA WITH 90-Y GLASS MICROSPHERES |
106 |
|
C.346 PRELIMINARY ASSESSMENT OF RADIONUCLIDIC PURITY OF CYCLOTRON PRODUCED 99MTC |
107 |
|
C.347 PRELIMINARY RADIONUCLIDIC PURITY ASSESSMENT OF 223RA |
107 |
|
C.348 PERFORMANCE EVALUATION OF AN ADAPTIVE THRESHOLD SEGMENTATION SOFTWARE FOR PET LESION DELINEATION |
107 |
|
C.349 QUANTITATIVE SPECT/CT IMAGING USING A COMMERCIAL SOFTWARE |
107 |
|
C.350 QUANTITATIVE 177LU SPECT IMAGING USING ADVANCED CORRECTION ALGORITHMS IN NON-REFERENCE GEOMETRY |
108 |
|
C.351 MICROSPHERES THERAPY OF LIVER TUMORS: CALCULATIONS AND MEASUREMENTS OF ABSORBED DOSES FOR NON-UNIFORM ACTIVITY DISTRIBUTIONS VIA 90Y-PET/CT IMAGING |
108 |
|
C.352 INTERNAL DOSE ASSESSMENT IN MOLECULAR RADIOTHERAPY: TIME FOR AN AGREED DOSIMETRY PROTOCOL? |
108 |
|
C.353 DOSIMETRIC VALIDATION AND COMPARISON OF A NOVEL ELECTRONIC DOSIMETRIC SYSTEM FOR NUCLEAR MEDICINE RADIATION PROTECTION |
109 |
|
C.354 PERFORMANCE OF MEDIPROBE COMPACT GAMMA CAMERA |
109 |
|
C.355 ABSOLUTE MEASUREMENT IN SITU OF THE 90Y ACTIVITY IN LIQUID SOLUTION BY TDCR METHOD AND CALIBRATION OF AN IONIZATION CHAMBER |
109 |
|
C.356 A NOVEL RADIOGUIDED SURGERY TECHNIQUE EXPLOITING BETA – DECAY |
109 |
|
C.357 A QUALITY CONTROL PROTOCOL FOR ROUTINE TESTS ON THE PHOSPHOR IMAGER CYCLONE PLUS |
110 |
|
C.358 90Y-PET/CT IMAGING QUANTIFICATION IN PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) |
110 |
|
C.359 EVALUATION OF FDG-PET/CT ROLE IN RADIOTHERAPY TREATMENT OF HEAD AND NECK CANCER |
110 |
|
C.360 COMPARISON STUDY OF TUMOUR UPTAKE DISTRIBUTION IN PRE AND POST TREATMENT IMAGING FOR 90Y LIVER RADIOEMBOLIZATION |
111 |
|
C.361 CALCULATION OF TUMOR AND NORMAL TISSUE BED IN 90Y LIVER RADIOEMBOLIZATION WITH DIFFERENT DOSIMETRIC METHODS |
111 |
|
C.362 A DIRICHLET PROCESS MIXTURE MODEL FOR AUTOMATIC 18F-FDG PET IMAGE SEGMENTATION |
111 |
|
C.363 OPTIMIZATION OF ACQUISITION PROTOCOL OF 11C-LABELED METHIONINE PET/CT |
111 |
|
C.364 GAMMA TOMOSYNTHESIS FOR MOLECULAR IMAGING |
112 |
|
C.365 MONTE CARLO AND CLINICAL STUDY OF THE IMPACT OF ATTENUATION AND SCATTER CORRECTIONS ON PROSPECTIVE 3D DOSIMETRY FOR RADIOEMBOLIZATION WITH 90Y MICROSPHERES |
112 |
|
C.366 ACCURATE MEASUREMENTS OF LOW ACTIVITY FOR CALIBRATION OF A RIA GAMMA COUNTER USED IN RED MARROW DOSIMETRY |
112 |
|
C.367 QUALITY ASSURANCE FOR PET/CT SYSTEM: NEMA NU2-2012 PROTOCOL ON THE NEW SIEMENS BIOGRAPH MCT FLOW |
113 |
|
C.368 NON-RIGID DEFORMATION OF MULTIPLE PET SERIES AND DOSE DISTRIBUTIONS FOR EVALUATING HEAD AND NECK CANCER RESPONSE TO RADIOTHERAPY |
113 |
|
C.369 NOISE STRUCTURE ANALYSIS IN [F-18]FDG-PET IMAGING: A MULTICENTER PHANTOM STUDY |
113 |
|
C.370 A NEW REGULARIZED RECONSTRUCTION ALGORITHM IN THE EVALUATION OF CONTRAST DETECTABILITY AND BACKGROUND VARIABILITY: COMPARISON WITH STANDARD OSEM ALGORITHM |
114 |
|
C.371 NOVEL LABR3:CE GAMMA CAMERA PROTOTYPE FOR ACCURATE COMPTON SCATTER REJECTION |
114 |
|
C.372 A MULTICENTER DOSIMETRIC AND OBSERVATIONAL STUDY FOR LESION DOSIMETRY IN 223RA THERAPY OF BONE METASTASES: CALIBRATION PROTOCOL AND ELIGIBILITY CRITERIA |
114 |
|
C.373 A STUDY OF MYOCARDIAL TOMOSCINTIGRAPHY BY SEMI-QUANTITATIVE ANALYSIS |
115 |
|
C.374 STUDY OF WHOLE BODY RESIDENCE TIMES FOR 131I TREATMENT OF THYROID CANCER |
115 |
|
C.375 RETROSPECTIVE ANALYSIS OF DOSE–RESPONSE FOR HCC LESIONS TREATED WITH 90Y RESIN MICROSPHERES |
115 |
|
C.376 RADIOMETABOLIC THERAPY WITH 131I FOR HYPERTHYROIDISM FROM GRAVES’ DISEASE. FIRST EXPERIENCES IN SASSARI HOSPITAL |
115 |
|
C.377 USE OF CUMULATIVE SUV VOLUME HISTOGRAM AS A NEW TOOL TO RADIOTHERAPY TREATMENT MONITORING |
116 |
|
C.378 NEW PROMISING SCINTILLATION CRYSTALS FOR MOLECULAR IMAGING APPLICATIONS: CRY018 AND CRY019 |
116 |
|
C.379 RED MARROW AND BLOOD DOSIMETRY IN 131I TREATMENT OF METASTATIC DIFFERENTIATED THYROID CARCINOMA: 7 YEARS EXPERIENCE AT MAURIZIANO HOSPITAL OF TURIN |
116 |
|
C.380 RADIOIODINE 131I TREATMENT OF DIFFERENTIATED THYROID CANCER IN PATIENTS UNDERGOING DIALYSIS: DOSIMETRY, RADIATION PROTECTION AND PRACTICAL ASPECTS |
117 |
|
C.381 RED MARROWDOSIMETRY IN DIFFERENTIATED THYROID CANCER (DTC): COMPARISON BETWEEN PREVISIONAL AND POST THERAPY DOSE FOR MULTITREATED PATIENTS AND FOLLOW-UP |
117 |
|
C.382 8F-FDG WHOLE BODY PET/CT DOSE EVALUATION IN PEDIATRIC PATIENTS |
117 |
|
C.383 A PROCEDURE TO QUANTIFY RADIONUCLIDE PURITY OF [18F]FDG BY MEANS OF GAMMA RAY SPECTROMETRY |
117 |
|
C.384 DIFFERENT POLAR-MAP PATTERNS USING THE NOVEL TECHNOLOGY FOR MYOCARDIAL PERFUSION IMAGING (MPI) |
118 |
|
C.385 CHARACTERIZATION OF A PET SCANNER FOR IMAGING WITH 68GA |
118 |
|
C.386 EFFECTIVE DOSE ESTIMATE IN PET-CT EXAMINATIONS |
118 |
|
C.387 EVALUATION OF COMMERCIAL SOFTWARE PERFORMANCE IN RETRIEVING INFORMATION FROM MERGED SPECT AND CT IMAGES: A PHANTOM STUDY |
119 |
|
C.388 ABSOLUTE GAMMA CAMERA CALIBRATION FOR QUANTITATIVE SPECT IMAGING WITH 177LU |
119 |
|
C.389 IMPACT OF ATTENUATION AND SCATTER CORRECTION IN PREVISIONAL DOSIMETRY BASED ON SPECT-CT IMAGES FOR RADIOEMBOLIZATION OF LIVER LESIONS WITH 90Y MICROSPHERES |
119 |
|
C.390 ACCURATE MONTE CARLO MODELING OF AN ACTIVITY METER USING FLUKA |
120 |
|
C.391 EXPERIENCE WITH ALPHA RADIATION THERAPY: PRELIMINARY PHYSICAL ASSESSMENT ON USING RA-223 |
120 |
|
C.392 PHYSICAL PERFORMANCE OF CLEARPEM, A DEDICATED SCANNER FOR POSITRON EMISSION MAMMOGRAPHY |
120 |
|
Radioprotection and BSS EURATOM Directive |
121 |
|
D.393 A SOFTWARE PACKAGE FOR DATA REGISTRATION AND ANALYSIS IN INTERVENTIONAL RADIOLOGY |
121 |
|
D.394 PEDIATRIC IN VIVO DOSIMETRY: A NOVEL PROCEDURE FOR RETINOBLASTOMA CHEMOEMBOLIZATION |
121 |
|
D.395 EXPERIMENTAL STUDY OF THE CORRELATION BETWEEN DAP AND OPERATOR EXPOSURE IN CARDIAC PROCEDURES |
121 |
|
D.396 AVERAGE GLANDULAR DOSE (AGD) IN MAMMOGRAPHY: RELIABILITY OF RECORDED DATA IN ORDER TO COMPLY TO COUNCIL DIRECTIVE 59/2013/ EURATOM |
122 |
|
D.397 A STATISTICAL ANALYSIS OF AVERAGE GLANDULAR DOSE IN 8900 PATIENTS WHO UNDERWENT CLINICAL MAMMOGRAPHY |
122 |
|
D.398 APPLICATION OF ICRP 60 AND ICRP 103 TISSUE WEIGHTING FACTORS FOR EVALUATION OF MEDICAL EXPOSURE TO EMILIA-ROMAGNA POPULATION FROM 2001 TO 2010 |
122 |
|
D.399 AGE AND SEX DISTRIBUTION OF EMILIA-ROMAGNA POPULATION RADIODIAGNOSTIC EXAMINATIONS FOR A RISK ASSESSMENT METHODOLOGY |
122 |
|
D.400 DECOMMISSIONING PROCEDURES FOR A 17 MEV MEDICAL CYCLOTRON |
123 |
|
D.401 DETERMINATION OF ATTENUATION PROPERTIES OF MATERIALS USED IN PROTECTIVE DEVICES AGAINST DIAGNOSTIC MEDICAL X-RADIATION FOLLOWING THE NEW CEI EN 61331-1 |
123 |
|
D.402 VALIDATION OF A PORTAL MONITOR FOR RADIOACTIVE HOSPITAL WASTES |
123 |
|
D.403 EVALUATION OF MEDICAL RADIATION EXPOSURES IN TUSCANY |
124 |
|
D.404 ASSESSMENT OF RADIONUCLIDE IMPURITIES IN 18F-METIL-CHOLINE (18F-FMECH) |
124 |
|
D.405 MONTE CARLO ESTIMATION AND MEASUREMENT OF THE ACTIVATION PRODUCTS DUE TO AN ELECTRON LINEAR ACCELERATOR FOR MEDICAL APPLICATIONS |
124 |
|
D.406 WHY NOT USE EFFECTIVE DOSE INDEX (EDI) INSTEAD OF EFFECTIVE DOSE (E) FOR THE INFORMATION RELATING TO PATIENT EXPOSURE? |
124 |
|
D.407 A WORK PROCESS-ORIENTED ANALYTICAL MODEL FOR THE CALCULATION OF DOSE AND RISK TO THE OPERATORS INVOLVED IN FLUOROSCOPIC PROCEDURES |
125 |
|
D.408 ATTENUATION OF PROTECTIVE EYEWEAR IN DIFFERENT GEOMETRIES: EXPERIMENTAL RESULTS |
125 |
|
D.409 STUDY OF A LINAC TARGET ACTIVATION |
125 |
|
D.410 ACTIVITY ESTIMATION IN PATIENTS SUBMITTED TO RADIOIODINE THERAPY FOR HYPERTHYROIDISM |
126 |
|
D.411 “OPERRA” PROJECT ON PRIORITIES FOR RESEARCH IN THE FIELD OF RADIATION PROTECTION: DEVELOPMENT OF A SURVEY |
126 |
|
D.412 QUALITY ASSURANCE AND MANAGEMENT PROGRAM OF INDIVIDUAL AND ENVIRONMENTAL RADIATION PROTECTION EQUIPMENT IN A ISO 9001: 2008 QUALITY MANAGEMENT SYSTEM |
126 |
|
D.413 ISO 17025 ACCREDITATION EXPERIENCE OF AN INDIVIDUAL MONITORING SERVICE |
126 |
|
D.414 ABSTRACT WITHDRAWN |
127 |
|
D.415 AUTOMATIC RADIATION DOSE TRACKING AS PART OF A REGIONAL PACS IN TUSCANY |
127 |
|
D.416 CT ORGAN DOSES AND EFFECTIVE DOSE CALCULATION USING PHYSICO®: AN AUTOMATIC DOSIMETRIC SOFTWARE |
127 |
|
D.417 INVESTIGATION ON NUCLEAR MEDICINE’S COUNTING WASTE: PRESENCE OF EU-152 WAS FOUND |
127 |
|
D.418 EXTREMITY DOSES ASSESSMENT OF NUCLEAR MEDICINE PERSONNEL INVOLVED IN 99MTC-RADIOPHARMACEUTICALS PREPARATION: A MULTICENTER STUDY – PRELIMINARY RESULTS |
128 |
|
D.419 PATIENT DOSIMETRIC EVALUATION IN ANGIOGRAPHY PRACTICE: APPLICATION IN INTERVENTIONAL NEURORADIOLOGY |
128 |
|
Developments in MRI |
129 |
|
E.420 EXPOSURE TO STATIC MAGNETIC FIELDS IN NMR RESEARCH LABORATORIES |
129 |
|
E.421 DIFFUSE AND LOCAL MYOCARDIAL FIBROSIS EVALUATED BY MEANS OF T1-3D VOLUMETRIC MAPPING. INITIAL CLINICAL EXPERIENCE |
129 |
|
E.422 NOVEL MRI QUALITY ASSURANCE PROCEDURE BASED ON SIGNAL TO NOISE RATIO LINEARITY |
129 |
|
E.423 RENAL FUNCTION ASSESSMENT BY TEXTURE ANALYSIS OF R2 MAP |
130 |
|
E.424 RECTAL CANCER TEXTURE ANALYSIS APPLIED ON ADC MAPS IN RESPONSE ASSESSMENT TO NEOADJUVANT THERAPY |
130 |
|
E.424 bis A NEW REFINED ACOUSTIC AND THERMAL COUPLING MODEL FOR TEMPERATURE RISE IN MR-GUIDED HIFU |
130 |
|
E.425 ANALYSIS OF SIMULTANEOUS EEG/FMRI DATA ACQUISITION IN EPILEPTIC PATIENTS: COMPARISON OF SEMI-BLIND ICA, SPATIAL ICA AND GLM BASED METHODS |
131 |
|
E.426 HIGH-FIELD MR SPECTROSCOPY IN THE MULTIPARAMETRIC MRI EVALUATION OF BREAST LESIONS |
131 |
|
E.427 FIBROSING LIVER DISEASES IN PAEDIATRIC AGE: MRI INVESTIGATION BY DIAGNOSTIC MAPS OF SLOW DIFFUSION AND FAST DIFFUSION GENERATED FROM A MULTIPLE B VALUES DWI |
131 |
|
E.428 ACCURACY OF THE GRASE SEQUENCE IN EVALUATING T2 RELAXATION TIME |
131 |
|
E.429 QUALITY ASSURANCE OF PHASED ARRAY COILS: ANALYSIS OF THE NOISE AMPLIFICATION FACTOR DISTRIBUTION |
132 |
|
E.430 IMPLEMENTING INTRA-OPERATIVE MAGNETIC RESONANCE IMAGING EQUIPMENT – SAFETY CONCERNS |
132 |
|
E.431 TEMPORAL STABILITY QA IN FUNCTIONAL MAGNETIC RESONANCE IMAGING |
132 |
|
E.432 SAFETY FOR MRI PATIENTS WITH IMPLANTED MEDICAL DEVICES |
132 |
|
E.433 MRI FERROMAGNETIC DETECTOR SYSTEM FOR PATIENTS’ AND OPERATORS’ SAFETY: EXPERIENCE IN OPBG |
133 |
|
E.434 MACHINE LEARNING TECHNIQUES IMPLEMENTED ON STRUCTURAL MRI FEATURES AT DIFFERENT SPATIAL SCALES FOR PRESCHOOLERS WITH AUTISM SPECTRUM DISORDERS |
133 |
|
E.435 A CUSTOM-MADE MR-COMPATIBLE PASSIVE DEVICE FOR FMRI INVESTIGATIONS IN NEURAL CORRELATES OF ANKLE MOVEMENTS DURING MOTOR TASKS |
133 |
|
E.436 ARTERIAL SPIN LABELING (ASL) TECHNIQUE COULD BE USED AS STANDARD CLINICAL TOOL? |
134 |
|
E.437 TRANS-CRANIAL MRI-GUIDED FOCUSED ULTRASOUND SURGERY (TCMRGFUS): ITALIAN AND WORLD-FIRST EXPERIENCE AT 1.5 TESLA |
134 |
|
E.438 COMPARATIVE EVALUATION OF DATA PREPROCESSING SOFTWARE TOOLS TO INCREASE EFFICIENCY AND ACCURACY IN DIFFUSION KURTOSIS IMAGING |
134 |
|
E.439 RESTING STATE FMRI: A TOOL TO INVESTIGATE FUNCTIONAL CONNECTIVITY MODULATION INDUCED BY TRANSCRANIAL DIRECT CURRENT STIMULATION OF THE MOTOR NETWORK |
134 |
|
E.440 LONG TERM SIGNAL TO NOISE RATIO ANALYSIS OF MAGNETIC RESONANCE IMAGES FROM MULTICOIL ARRAY |
135 |
|
E.441 MAPPING OF THE RESPONSE OF A 16 ELEMENT PHASED-ARRAY COIL USED FOR BREAST MRS |
135 |
|
E.442 DIFFUSION KURTOSIS IMAGING IN HEAD AND NECK AND BRAIN TUMOR: A FEASIBILITY STUDY |
135 |
|
E.443 IMPROVING DIFFERENTIAL DIAGNOSIS OF BREAST LESIONS WITH ADC AND DCE KINETIC DESCRIPTORS |
136 |
|
E.444 LOSS OF REPRODUCIBILITY IN A TASK BRAIN |
136 |
|
E.445 BRAIN SIZE BIAS CORRECTION METHOD IN A VOLUMETRIC GROUP ANALYSIS: THEORY AND NORMALIZATION |
136 |
|
E.446 COMPARISON OF PCA VS KPCA FOR PHYSIOLOGICAL NOISE REMOVAL IN RESTING STATE FMRI |
136 |
|
E.447 MRI QUANTIFICATION OF NON-GAUSSIAN WATER DIFFUSION IN WHITE AND GRAY MATTERS: AN IN-VIVO DKI STUDY |
137 |
|
E.448 DKI AND PSEUDO-KURTOSIS IN PHANTOMS |
137 |
|
E.449 THE IMPORTANCE OF PERFORMING AN ACCURATE IMAGES PREPROCESSING IN MR DIFFUSION ANALYSIS |
137 |
|
E.450 AIFMMULTICENTER INTERCOMPARISON OF MR SCANNERS FOR PROTON SPECTROSCOPY – PRELIMINARY RESULTS |
138 |
|
E.451 QUANTITATIVE EVALUATION OF SUSCEPTIBILITY EFFECTS CAUSED BY DENTAL MATERIALS IN HEAD MAGNETIC RESONANCE IMAGING |
138 |
|
E.452 ARTEFACTS AND RELIABILITY IN 3D ATRIAL FIBROSIS SEGMENTATION OF DELAYED-ENHANCEMENT CARDIAC MRI |
138 |
|
E.453 ACCURACY COMPARISON OF TWO DIFFERENT OPTIMIZATION ALGORITHMS FOR DIRECT BI-EXPONENTIAL ANALYSIS OF IVIM MRI IMAGES |
139 |
|
Non-Ionizing Radiations |
140 |
|
F.454 COMMENTS ON THE SOUND PERCEPTION IN CONFINED ENVIRONMENT AND IMPLICATIONS ON HEARING AIDS |
140 |
|
F.455 NOISE EXPOSURE OF WORKERS AND PASSENGERS ON REGIONAL TRAINS IN CALABRIA |
140 |
|
F.457 DEVELOPMENT OF A COMPUTATIONAL TOOL FOR HIFU ABLATION THERAPY TO ASSURE SAFETY OF THE PATIENT |
140 |
|
F.458 SIMULTANEOUS USING OF TWO SUPERFICIAL HYPERTHERMIA ANTENNAS |
141 |
|
F.459 OPENING FRACTION TIME OF INTERNAL JUGULAR VALVES USING ULTRASOUND TRACES |
141 |
|
F.460 IMPLEMENTATION OF A QUALITY ASSURANCE PROGRAM FOR ULTRASOUND TRANSDUCERS |
141 |
|
F.461 HOW HTA METHODOLOGY IS ABLE TO HELP THE DECISION MAKER TO INTRODUCE MOST SUITABLE TECHNOLOGY |
141 |
|
F.462 ASSESSMENT OF WORKERS’ EXPOSURE DUE TO BLUE-LIGHT NEONATAL PHOTOTHERAPY |
142 |
|
F.463 ELECTROMAGNETIC FIELDS OF A NEW FERROMAGNETIC SURGICAL SYSTEM |
142 |
|
Education |
143 |
|
G.464 BIRTH OF LEDA (LABORATORY FOR EDUCATION IN DOSIMETRY ANALYSES) IN MEDICAL PHYSICS AND RADIOTHERAPY DEPARTMENTS |
143 |
|
G.465 THE AIFM WEB SECTION ‘ILFISICOMEDICORISPONDE’ TWO YEARS FROM THE START: CONSIDERATIONS, CRITICAL POINTS AND FUTURE DEVELOPMENTS |
143 |
|
G.466 ICTP, TRIESTE UNIVERSITY AND ITALIAN MEDICAL PHYSICS: A TRAINING OPPORTUNITY FOR YOUNG PHYSICISTS FROM DEVELOPING COUNTRIES |
143 |